AMSINO CLOSED THE ASSET PURCHASE AGREEMENT TO ACQUIRE SMITHS MEDICAL’S VERNON HILL’S PLANT
Pomona, CA —Amsino Medical Group is pleased to announce the closing of the previously announced Asset Purchase Agreement today with Smiths Medical ASD, Inc. (Smiths) to acquire the assets of Smiths’ manufacturing plant located in Vernon Hills, Illinois (VH). The transaction includes all assets and infrastructure that currently exist in the facility.
Posted: October 31, 2018 | News
AMSINO TO ATTEND MEDICA 2018 IN DUSSELDORF, GERMANY
Pomona, CA - Amsino is pleased to announce their attendance at MEDICA in Dusseldorf, Germany November 12-15, 2018. The Amsino stand will be in the USA Pavilion, Hall 16 E40-8.
Amsino receives FDA approval for hydrophillic intermittent catheters
Pomona, Ca — Amsino Medical Group announces FDA approval via a 510(k) for hydrophilic intermittent urology catheters and kits. The products are complimentary to the Amsino portfolio of urological products and utilize existing coating technologies and expertise. The hydrophilic coating will be combined with Amsino’s R-Polished® technology to a provide a superior product for self-catheterization and clinical use.
Amsino Medical Group to Acquire Smiths Medical’s Vernon Hills’s Manufacturing Plant
Pomona, Ca — Amsino Healthcare (USA), Inc., a fully owned subsidiary of Amsino Medical Group (“Amsino”) has signed a definitive agreement with Smiths Medical ASD, Inc. (Smiths) to acquire the assets of Smiths’ manufacturing plant located in Vernon Hills, IL (VH). The transaction includes all assets and infrastructure that currently exist in the facility. The plant has been a long-time FDA registered pharmaceutical manufacturer of essential inhalation therapy, wound care and other USP grade saline/water based products for the medical device and pharmaceutical industries. The acquisition is in alignment with Amsino’s strategic global expansion goals and its mission to improve the safety and effectiveness of patient care worldwide. The transaction is expected to close in the second half of 2018.
AMSure® Pre-filled Syringe for Balloon Inflation Receives FDA 510(k) Clearance
Pomona, Ca — Amsino Medical Group announces that the new AMSure® pre-filled syringe for balloon inflation with sterile water has received United States Food and Drug Administration (FDA) 510(k) clearance as a Urological Catheter and Accessories, Class II device for indwelling catheter balloon inflation applications. Amsino has expanded its manufacturing capabilities to include the production of sterile saline water products. This new clearance is a first in a series of advancements and sterile water product line extensions at Amsino.